Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Terra Universal’s BioSafe™ Pass-Through Chambers meet requirements for clean, aseptic processing in biotech, pharmaceutical, medical device, and other critical applications. These 304/316 electro-polished stainless steel pass-throughs feature a seamless design with coved corners and ultra-smooth surfaces that eliminates cracks, corners and other contaminant traps, making them easy to clean and sterilize. No-lip edges eliminate clearance obstructions for easy material transfer into and out of a bio-cleanroom.
Charles Drew University of Medicine and Science broke ground on the $43 million Life Sciences Research and Nursing Education Building in Los Angeles on April 18, 2008. The two-story, 63,000-sf building will house comprehensive nursing instruction for the Mervyn S. Dymally School of Nursing, and biomedical and clinical research laboratories for the College of Medicine and the College of Science and Health. Completion is expected by fall 2009. The architectural firm for project is HOK.
Alcon will break ground in 2009 on a 250,000-sf pharmaceutical manufacturing plant in Singapore. The facility will be sited on 20 acres in the Tuas Biomedical Park and will employ 150 workers. The plant is expected to begin operations in 2012. Alcon, based in Huenenberg, Switzerland, researches and manufactures pharmaceuticals, surgical equipment, and devices for the ophthalmic industry.
The University of British Columbia is engaged in a $45 million expansion and renovation of the Sauder School of Business in Vancouver. The project contractor is Scott Construction, a subsidiary of Vancouver-based Aecon Group. The project will create new career and business centers and will involve the renovation of a five-story lecture hall and library. Completion is slated for October 2009.
Developer JTC Corp. broke ground in April of 2008 on the $100 million Biopolis III building in Singapore. The 41,500-sm facility will consist of two buildings accommodating biomedical research and incubator space. Completion is slated for the fourth quarter of 2009. Crescendas Bionix will occupy at least 50 percent of the facility. A construction start date for the 30,000-sm Biopolis IV has yet to be announced. Biopolis, a biomedical research and development park, is located at One-North in Buona Vista.
